Joseph Fogerty

Joseph Fogerty has a diverse work experience in the field of scientific research. Joseph began their career at the Medical College of Wisconsin, where they worked as a Laboratory Technologist from June 2000 to July 2003 and later as a Laboratory Manager from July 2003 to August 2007. During their time there, they gained expertise in laboratory operations and management.

In 2013, Fogerty joined the Cleveland Clinic as a Postdoctoral Fellow, specializing in studying the role of microRNAs in retinal development and function using zebrafish as a model organism. Joseph utilized advanced gene editing technologies such as CRISPR and TALEN to generate mutations in specific microRNAs involved in photoreceptor function. Their research aimed to understand the mechanisms behind visual perception initiation.

Currently, Fogerty is employed at Abeona Therapeutics, starting as a Scientist in October 2021 and eventually achieving the position of Senior Scientist in January 2023. Although the end dates for their roles at Abeona Therapeutics are not provided, their work in this company showcases their expertise and continued growth in scientific research and development.

Overall, Fogerty's career trajectory demonstrates their dedication to scientific research and their ability to contribute valuable insights and expertise in the field.

Joseph Fogerty's education history begins in 1996 when they enrolled at Carroll University. Joseph studied biology and completed their Bachelor of Science (BS) degree in 2000.

Following that, Fogerty pursued further education at the Medical College of Wisconsin, starting in 2007. Joseph completed their Doctor of Philosophy (PhD) degree in 2013, specializing in the field of Cell Biology, Neurobiology, and Anatomy.